UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 201

Sortiert nach

Milvexian for the Prevention of Venous Thromboembolism

The New England journal of medicine, 2021-12, Vol.385 (23), p.2161-2172

2021

Volltextzugriff (PDF)

Semuloparin for Thromboprophylaxis in Patients Receiving Chemotherapy for Cancer

The New England journal of medicine, 2012-02, Vol.366 (7), p.601-609

2012

Volltextzugriff (PDF)

Rivaroxaban versus Enoxaparin for Thromboprophylaxis after Total Knee Arthroplasty

The New England journal of medicine, 2008-06, Vol.358 (26), p.2776-2786

2008

Volltextzugriff (PDF)

Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty (RECORD4): a randomised trial

The Lancet (British edition), 2009-05, Vol.373 (9676), p.1673-1680

2009

Volltextzugriff (PDF)

Use of the Low-Molecular-Weight Heparin Reviparin to Prevent Deep-Vein Thrombosis after Leg Injury Requiring Immobilization

The New England journal of medicine, 2002-09, Vol.347 (10), p.726-730

2002

Volltextzugriff (PDF)

Effect of Osocimab in Preventing Venous Thromboembolism Among Patients Undergoing Knee Arthroplasty: The FOXTROT Randomized Clinical Trial

JAMA : the journal of the American Medical Association, 2020-01, Vol.323 (2), p.130

2020

Volltextzugriff (PDF)

Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)

Chest, 2008-06, Vol.133 (6 Suppl), p.381S-453S

2008

Volltextzugriff (PDF)

Superiority of Fondaparinux Over Enoxaparin in Preventing Venous Thromboembolism in Major Orthopedic Surgery Using Different Efficacy End Points

Chest, 2004-08, Vol.126 (2), p.501-508

2004

Volltextzugriff (PDF)

Prevention of venous thromboembolism: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy

Chest, 2004-09, Vol.126 (3), p.338S-400S

2004

Volltextzugriff (PDF)

Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trial

BMJ (British Medical Journal), 2006-02, Vol.332 (7537), p.325-327

International edition, 2006

Volltextzugriff (PDF)

A non-interventional comparison of rivaroxaban with standard of care for thromboprophylaxis after major orthopaedic surgery in 17,701 patients with propensity score adjustment

Thrombosis and haemostasis, 2014-01, Vol.111 (1), p.94

2014

Volltextzugriff (PDF)

Fondaparinux Compared with Enoxaparin for the Prevention of Venous Thromboembolism after Hip-Fracture Surgery

The New England journal of medicine, 2001-11, Vol.345 (18), p.1298-1304

2001

Volltextzugriff (PDF)

Fondaparinux Compared with Enoxaparin for the Prevention of Venous Thromboembolism after Elective Major Knee Surgery

The New England journal of medicine, 2001-11, Vol.345 (18), p.1305-1310

2001

Volltextzugriff (PDF)

Preoperative Enoxaparin Versus Postoperative Semuloparin Thromboprophylaxis in Major Abdominal Surgery: A Randomized Controlled Trial

Annals of surgery, 2014-06, Vol.259 (6), p.1073-1079

2014

Volltextzugriff (PDF)

Postoperative fondaparinux versus postoperative enoxaparin for prevention of venous thromboembolism after elective hip-replacement surgery: a randomised double-blind trial

The Lancet (British edition), 2002-05, Vol.359 (9319), p.1721-1726

2002

Volltextzugriff (PDF)

Rivaroxaban compared with standard thromboprophylaxis after major orthopaedic surgery: co‐medication interactions

British journal of clinical pharmacology, 2016-04, Vol.81 (4), p.724-734

2016

Volltextzugriff (PDF)

Recent developments in the use of oral anticoagulants

Expert opinion on pharmacotherapy, 2009-08, Vol.10 (11), p.1769-1781

Lassen, Michael R

2009

Volltextzugriff (PDF)

Darexaban (YM150) versus enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: a randomised phase IIb dose confirmation study (ONYX-3)

Thrombosis and haemostasis, 2014-02, Vol.111 (2), p.213

2014

Volltextzugriff (PDF)

Fondaparinux, the first selective factor Xa inhibitor

Current opinion in hematology, 2003-09, Vol.10 (5), p.327-332

2003

Volltextzugriff (PDF)

Rivaroxaban for Thromboprophylaxis After Fracture-Related Orthopedic Surgery in Routine Clinical Practice

Clinical and applied thrombosis/hemostasis, 2016-03, Vol.22 (2), p.138-146

2016

Volltextzugriff (PDF)

Prothrombin fragment 1 + 2 in urine as a marker on coagulation activity in patients with suspected pulmonary embolism

Thrombosis research, 2014-07, Vol.134 (1), p.68-71

2014

Volltextzugriff (PDF)

Thrombin split products (prothrombin fragment 1 + 2) in urine in patients with suspected deep vein thrombosis admitted for radiological verification

Thrombosis research, 2013-06, Vol.131 (6), p.560-563

2013

Volltextzugriff (PDF)

Urinary Prothrombin Fragment 1+2 in relation to Development of Non-Symptomatic and Symptomatic Venous Thromboembolic Events following Total Knee Replacement

Thrombosis, 2011-01, Vol.2011, p.150750-6

2011

Volltextzugriff (PDF)

Rationale and design of XAMOS: noninterventional study of rivaroxaban for prophylaxis of venous thromboembolism after major hip and knee surgery

Vascular health and risk management, 2012-01, Vol.8 (default), p.363-370

2012

Volltextzugriff (PDF)

Duration of prophylaxis against venous thromboembolism with fondaparinux after hip fracture surgery: a multicenter, randomized, placebo-controlled, double-blind study

Archives of internal medicine (1960), 2003-06, Vol.163 (11), p.1337

2003

Volltextzugriff (PDF)

1 – 25 von 201

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(188)
Mit Volltextzugriff
(178)

Publikationsform

Artikel
(201)

Sprache

Englisch
(201)
Japanisch
(17)

Erscheinungsjahr

n.n

Thema

Science & Technology
(133)
Life Sciences & Biomedicine
(127)
Humans
(119)
Male
(82)
Female
(77)
Middle Aged
(69)
Aged
(60)
Biological And Medical Sciences
(54)
Cardiovascular System & Cardiology
(54)
Medical Sciences
(50)
Treatment Outcome
(39)
Adult
(38)
General & Internal Medicine
(33)
Postoperative Complications - Prevention & Control
(30)
Venous Thrombosis - Prevention & Control
(30)
Cardiac & Cardiovascular Systems
(29)
Hematology
(29)
Medicine, General & Internal
(29)
Peripheral Vascular Disease
(28)
Surgery
(27)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Milvexian for the Prevention of Venous Thromboembolism

Semuloparin for Thromboprophylaxis in Patients Receiving Chemotherapy for Cancer

Rivaroxaban versus Enoxaparin for Thromboprophylaxis after Total Knee Arthroplasty

Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty (RECORD4): a randomised trial

Use of the Low-Molecular-Weight Heparin Reviparin to Prevent Deep-Vein Thrombosis after Leg Injury Requiring Immobilization

Effect of Osocimab in Preventing Venous Thromboembolism Among Patients Undergoing Knee Arthroplasty: The FOXTROT Randomized Clinical Trial

Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)

Superiority of Fondaparinux Over Enoxaparin in Preventing Venous Thromboembolism in Major Orthopedic Surgery Using Different Efficacy End Points

Prevention of venous thromboembolism: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy

Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trial

A non-interventional comparison of rivaroxaban with standard of care for thromboprophylaxis after major orthopaedic surgery in 17,701 patients with propensity score adjustment

Fondaparinux Compared with Enoxaparin for the Prevention of Venous Thromboembolism after Hip-Fracture Surgery

Fondaparinux Compared with Enoxaparin for the Prevention of Venous Thromboembolism after Elective Major Knee Surgery

Preoperative Enoxaparin Versus Postoperative Semuloparin Thromboprophylaxis in Major Abdominal Surgery: A Randomized Controlled Trial

Postoperative fondaparinux versus postoperative enoxaparin for prevention of venous thromboembolism after elective hip-replacement surgery: a randomised double-blind trial

Rivaroxaban compared with standard thromboprophylaxis after major orthopaedic surgery: co‐medication interactions

Recent developments in the use of oral anticoagulants

Darexaban (YM150) versus enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: a randomised phase IIb dose confirmation study (ONYX-3)

Fondaparinux, the first selective factor Xa inhibitor

Rivaroxaban for Thromboprophylaxis After Fracture-Related Orthopedic Surgery in Routine Clinical Practice

Prothrombin fragment 1 + 2 in urine as a marker on coagulation activity in patients with suspected pulmonary embolism

Thrombin split products (prothrombin fragment 1 + 2) in urine in patients with suspected deep vein thrombosis admitted for radiological verification

Urinary Prothrombin Fragment 1+2 in relation to Development of Non-Symptomatic and Symptomatic Venous Thromboembolic Events following Total Knee Replacement

Rationale and design of XAMOS: noninterventional study of rivaroxaban for prophylaxis of venous thromboembolism after major hip and knee surgery

Duration of prophylaxis against venous thromboembolism with fondaparinux after hip fracture surgery: a multicenter, randomized, placebo-controlled, double-blind study

Suchergebnisse filtern